Loading...
XHKG3869
Market cap118mUSD
Nov 29, Last price  
6.70HKD
Name

Hospital Corporation of China Ltd

Chart & Performance

D1W1MN
XHKG:3869 chart
P/E
6.57
P/S
0.60
EPS
0.96
Div Yield, %
0.00%
Shrs. gr., 5y
8.05%
Rev. gr., 5y
30.06%
Revenues
1.43b
+24.92%
28,383,600142,524,000161,385,000149,158,000383,610,000410,883,000399,214,000520,290,0001,142,951,0001,427,733,000
Net income
131m
P
2,480,40050,935,00024,068,000-13,749,000-50,490,000150,900,000-421,069,000-362,396,000-528,597,000131,384,000
CFO
83m
-42.23%
3,639,6007,445,000164,039,00047,071,000122,351,00062,984,00083,485,000133,069,000143,135,00082,691,000
Earnings
Jun 20, 2025

Profile

Hospital Corporation of China Limited, an investment holding company, engages in the operation and management of hospitals in the People's Republic of China. The company provides hospital management and consulting services to Yangsi Hospital, Cixi Hospital, and Jinhua Hospital; and general hospital services. It also engages in the wholesale of pharmaceutical products. The company was incorporated in 2014 and is headquartered in Beijing, the People's Republic of China. Hospital Corporation of China Limited is a subsidiary of Vanguard Glory Limited.
URL
http://www.hcclhealthcare.com/
IPO date
Mar 16, 2017
Employees
1,437
Domiciled in
CN
Incorporated in
KY

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑122014‑12
Income
Revenues
1,427,733
24.92%
1,142,951
119.68%
520,290
30.33%
Cost of revenue
1,319,173
1,087,575
403,941
Unusual Expense (Income)
NOPBT
108,560
55,376
116,349
NOPBT Margin
7.60%
4.85%
22.36%
Operating Taxes
47,860
(4,031)
(86,706)
Tax Rate
44.09%
NOPAT
60,700
59,407
203,055
Net income
131,384
-124.86%
(528,597)
45.86%
(362,396)
-13.93%
Dividends
(30,791)
Dividend yield
Proceeds from repurchase of equity
(6,379)
BB yield
Debt
Debt current
91,573
1,207,466
85,778
Long-term debt
954,406
14,007
923,644
Deferred revenue
Other long-term liabilities
237,101
49,111
368,602
Net debt
412,122
593,868
229,451
Cash flow
Cash from operating activities
82,691
143,135
133,069
CAPEX
(9,271)
(16,649)
(15,796)
Cash from investing activities
(15,518)
187,163
13,955
Cash from financing activities
(41,615)
(279,343)
(550,820)
FCF
62,360
388,093
(162,864)
Balance
Cash
667,891
627,605
779,971
Long term investments
(34,034)
Excess cash
562,470
570,457
753,956
Stockholders' equity
(712,059)
8,124
700,523
Invested Capital
2,577,322
1,666,110
1,777,177
ROIC
2.86%
3.45%
10.40%
ROCE
5.82%
3.03%
4.38%
EV
Common stock shares outstanding
202,161
138,194
138,194
Price
Market cap
EV
EBITDA
171,422
118,655
157,494
EV/EBITDA
Interest
4,417
4,909
6,092
Interest/NOPBT
4.07%
8.86%
5.24%